Detalhe da pesquisa
1.
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohort.
Breast Cancer Res Treat
; 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38703285
2.
Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study.
Breast Cancer Res Treat
; 203(1): 163-172, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773555
3.
A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Negative Metastatic Breast Cancer.
Oncologist
; 24(11): e1024-e1033, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31023863
4.
A Dalbavancin for Successful Treatment of Infective Endocarditis Caused by Enterococcus faecalis.
Eur J Case Rep Intern Med
; 10(1): 003654, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819647
5.
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab.
JAMA Oncol
; 9(6): 841-846, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37103916
6.
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Ther Adv Med Oncol
; 15: 17588359221148921, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36743520
7.
HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping.
Cancers (Basel)
; 14(3)2022 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158778
8.
New target-based agents involve new clinical trial designs.
Clin Transl Oncol
; 8(8): 581-7, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16952846
9.
Brain metastases in metastatic breast cancer patients receiving trastuzumab-based therapies.
Clin Transl Oncol
; 8(1): 50-3, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16632440
10.
New target-based agents involve new clinical trial designs
Clin. transl. oncol. (Print)
; 8(8): 581-587, ago. 2006. ilus
Artigo
em En
| IBECS (Espanha) | ID: ibc-047716
11.
Brain metastases in metastatic breast cancer patients receiving trastuzumab-based therapies
Clin. transl. oncol. (Print)
; 8(1): 50-53, ene. 2006. tab
Artigo
em En
| IBECS (Espanha) | ID: ibc-047626